Examining a Common Complaint of Women Who Receive Chemotherapy for Breast Cancer- Cognitive Difficulty
Completed
Conditions studied: Breast Cancer, Neurocognitive Impairment, Quality of Life
In brief
This longitudinal project will investigate a common complaint of women who receive chemotherapy for breast cancer- cognitive difficulty. The relationships of fatigue, stress, and depression to cognitive difficulties will be examined. The findings should lead to interventions to decrease the effects of these problematic side effects.
Key facts
- Study ID
- NCT01553097
- Run by
- Virginia Commonwealth University
- People needed
- 51
- Starts
- 2012-03-01
- Expected to finish
- 2014-05-01
- Last updated by the study team
- 2014-12-16
Who can join
Age: 21 and older. Sex: female. Healthy volunteers: accepted.
You may qualify if…
- read and speak English
- be physically able to take the computerized test (press the keyboard space bar and numerical keys "1" and "2" without difficulty)
- have an ECOG Performance Status score < 2.154
- capable of providing informed consent.
You may not qualify if…
- psychiatric impairment, such as organic brain disorders, mental retardation, active psychoses or dissociative disorders, or unstable and/or severe depressive illness.
Where it is running
- Virnigia Commonwealth University — Richmond, Virginia, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.